1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (1488)
  2. Journal Article (1179)
  3. Review (70)
  4. Research Letter (46)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (23)
  8. Correspondence (17)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (2899)
  2. Center for Hematologic Malignancies (2899)
  3. Department of Medicine (2899)
  4. Hematologic Malignancies, Division of (2776)
  5. Survivorship Research (1345)
  6. GSK Faculty (917)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Sean Devlin (457)
  4. Ann Jakubowski (456)
  5. Heather Landau (419)
  6. Gunjan Shah (418)

More People

Years
  1. 2025 (40)
  2. 2024 (169)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (840)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (125)
  5. Transplantation and Cellular Therapy (110)
  6. Blood Advances (88)

More Publications

Publishers
  1. American Society of Hematology (935)
  2. Elsevier Inc. (762)
  3. Nature Publishing Group (258)
  4. American Society of Clinical Oncology (127)
  5. Wiley Blackwell (65)
  6. Taylor & Francis Group (64)

More Publishers

Results (2899)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An open-label, single-arm study of letermovir (LTV) for prevention of recurrent CMV infection in highrisk allogeneic hematopoietic cell transplant (HCT) recipients
    Meeting Abstract

    Han, G.; Su, Y.; Stern, A.; Shaffer, B.; Perales, M. A.; Young, J. A.; Papanicolaou, G. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel versus standard regimens in patients with triple-class–exposed relapsed and refractory multiple myeloma: KarMMa-3, a phase 3 randomized controlled trial
    Meeting Abstract

    Rodríguez-Otero, P.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; Vij, R.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients
    Journal Article

    Laracy, J. C.; Yan, J.; Steiger, S. N.; Tan, C. A.; Cohen, N.; Robilotti, E. V.; Fender, J.; Cohen, S.; Korde, N.; Lee-Teh, M.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
    Journal Article

    Elias, S.; Brown, S.; Devlin, S. M.; Barker, J. N.; Cho, C.; Chung, D. J.; Dahi, P. B.; Giralt, S.; Gyurkocza, B.; Jakubowski, A. A.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Randomized phase II trial of dendritic cell/myeloma fusion vaccine with lenalidomide maintenance after upfront autologous hematopoietic cell transplantation for multiple myeloma: BMT CTN 1401
    Journal Article

    Chung, D. J.; Shah, N.; Wu, J.; Logan, B.; Bisharat, L.; Callander, N.; Cheloni, G.; Anderson, K.; Chodon, T.; Dhakal, B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
    Journal Article

    Lin, A.; Brown, S.; Chinapen, S.; Lee, Y. J.; Seo, S. K.; Ponce, D. M.; Shahid, Z.; Giralt, S.; Papanicolaou, G. A.; Perales, M. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT features as potent imaging biomarkers of efficacy and toxicity in large-B-cell lymphoma treated with CAR-T cell therapy
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Mauguen, A.; Devlin, S. M.; Fei, T.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; Lafontaine, D.; Michaud, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save